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Abstract 
Background. Recent guidelines support more aggressive surgery for aneurysms of the ascending 
aorta and root in patients with bicuspid aortic valve.  However, the fate of the arch after surgery of the 
root and ascending aorta is unknown.  We set out to assess outcomes following root and ascending 
aortic surgery and subsequent growth of the arch. 
Methods. Between 2005 and 2016, 536 consecutive patients underwent surgery for aneurysm of the 
root and ascending aorta. 168 had bicuspid aortic valve.  Patients with dissection were excluded. Arch 
diameter was measured before and after surgery, at six months and then annually.  
Results. Of 168 patients, 127 (75.6%) had aortic root replacement and 41 (24.4%) had ascending 
replacement. Mean age was 57±12.8 years, 82.7% were males and five operations were performed 
during pregnancy.   There was one (0.6%) hospital death.  One (0.6%) patient had a stroke and one 
(0.6%) had re-sternotomy for bleeding.  Median ICU and hospital stays were 1 and 6 days 
respectively.   Follow-up was complete for 94% at a median of 5.9 years (1-139 months). Aortic arch 
diameter was 2.9 cm preoperatively and 3.0 cm at follow-up. There was 97% freedom from 
reoperation and none of the patients required surgery on the arch. 
Conclusions. Prophylactic arch replacement during aortic root and ascending aortic surgery in 
patients with bicuspid aortic valve is not supported.  Our data does not support long term surveillance 
of the rest of the aorta in this population.  
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Diseases of the aortic root and ascending aorta carry significant risks of morbidity and mortality [1]. 
There is an incremental risk of aortic dissection with increasing aortic diameter [2]. Until recently, 
guidelines recommended aortic surgery when the diameter reached ≥ 5.5 cm in non syndromic 
patients [2,3].  Despite these guidelines, up to one third of patients presenting with aortic dissection 
have diameters below 5.5 cm [1,4,5].  Several studies have demonstrated that operative management 
of patients with bicuspid aortic valves (BAV) should not be extrapolated from Marfan syndrome 
treatment algorithms [6]. Indications for concomitant intervention on the thoracic aorta at the time of 
aortic valve replacement (AVR) are controversial [6] and data are limited with regard to the aortic 
diameter at which the risk of dissection is high enough to warrant replacement of the ascending aorta 
at the time of AVR, particularly in patients with BAV [7]. Due to the paucity of data, and institutional 
differences in operative mortality,  the referral for surgery in patients with aortic root and ascending 
aortic aneurysm varies.   
Furthermore, there are no specific guidelines on whether or at what size to replace the arch 
prophylactically at the time of surgery for the aortic root and ascending aorta. We and others believe 
that BAV aortopathy is mainly confined to the ascending aorta and that the abnormal flow patterns 
created in the ascending aorta and arch as a result of BAV may potentially, in a small percentage of 
cases, cause dilatation of the arch. However, we believe that this hemodynamic effect is removed 
following valve, root, and ascending aorta replacement [8,9].  
We set out to examine the outcomes of proximal thoracic aortic aneurysm surgery and to 
assess the subsequent growth of the aortic arch in patients with BAV who have undergone aortic root 
and / or ascending aortic replacement.   The associated risk of arch surgery can only be justified if the 
arch grows following proximal aortic surgery. 
 
Patients and Methods 
Study Population 
Between 2005 and 2016, data for consecutive patients undergoing elective and urgent ARR or 
ascending aorta replacement (AAR) with or without aortic valve replacement (AVR) and valve 
sparing root replacement (VSRR) under the care of one surgical team were prospectively collected. 
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All operations were performed by one attending (MJ) and residents of that team. The subset of 
patients with BAV is the subject of this study.  Patients undergoing concomitant aortic arch 
replacement and those with type A dissection were excluded. The latter group were excluded since 
they invariably had a part of the arch removed and therefore it is difficult to assess the growth of the 
arch during follow-up. Additionally, patients with known connective tissue disease like Marfan 
syndrome were also excluded. Approval from the research ethics committee (IRB equivalent) was 
obtained.  
 Data collection was performed by two researchers and database manager, and checked with 
the main surgical database which is submitted to the National Institute for Cardiovascular Outcomes 
Research (NICOR) at The Society for Cardiothoracic Surgery of GB & Ireland (SCTS) [10,11].  
Operative mortality, peri-operative complications, growth of the aortic arch and the need for 
further surgery or intervention either on the aortic root, valve or arch during follow-up were analysed. 
 
Definitions 
Elective surgery was defined as planned surgery performed at more than one week from the decision 
to operate. Urgent surgery was defined as surgery performed more than 24 hours, but less than one 
week, after unplanned hospital admission. Diagnosis of BAV was made by imaging and then 
confirmed at the time of surgery.   
The presence of connective tissue disorder was confirmed with genetic analysis and/or 
histological examination of the excised aorta or by clinical criteria, such as the modified Ghent 
criteria [12]. Operative mortality was death before hospital discharge. Post-operative transient 
ischemic attack or stroke was based on new brain injury diagnosed either clinically or radiologically. 
Postoperative renal dysfunction was defined as needing hemofiltration in patients who were not 
previously dialysed. 
 
Imaging Before Surgery and Measurements of Aorta at Follow-up  
Aortic dimensions were measured either from CT scans or MRI. Based on the 2014 European Society 
of Cardiology (ESC) guidelines, measurement of the aorta included the aortic wall [3]. The mid aortic 
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arch was measured between the left common carotid artery and the left subclavian artery (Fig. 1). For 
aortic sinuses, transthoracic echocardiography was used, with measurements taken during diastole 
using the leading edge to edge technique [13]. 
 
Study Definitions 
In the presence of aortic valve pathology, if the aortic root and/or sinuses were >4.5 cm, ARR was 
performed with ascending aorta replacement.  If the aortic root was <4.5 cm, but ascending aorta was 
> 4.5 cm, only the ascending aorta was replaced. AVR was performed based on standard indications 
[14]. In patients with dilated sinuses, but where the valve was normal or near normal, valve sparing 
aortic root replacement (VSRR) was performed. Other factors taken into account were positive family 
history, rate of growth and the decision of future pregnancy in females. Patients with pathology of the 
arch requiring arch replacement were excluded. Our standard practice is to replace the aortic arch at a 
diameter of ≥ 4.5cm. 
 
Anesthetic Protocol and Perioperative Care 
All patients underwent cerebral perfusion monitoring using near-infrared spectroscopy along with a 
treatment algorithm to manage low values during cardiopulmonary bypass (CPB). Hemoglobin on 
CPB was maintained above 8 g/dL. To assess coagulopathy, thromboelastography (Hemonetics™) 
and multiplatelet analyzer (Cobas Roche™) for platelet function were used.  We have described our 
protocols for surgery in pregnant patients previously [15].   
 
Surgical Technique 
CPB was established at 35oC through central or peripheral (axillary or femoral) cannulation and right 
atrial or bicaval cannulation. Circulatory arrest was not used in this cohort since patients requiring 
surgery for the arch were excluded.  Myocardial protection was achieved using antegrade cold blood 
based cardioplegic solution. 
Patients undergoing valve sparing root replacement (VSRR) underwent the remodelling 
technique [16]. For patients requiring a bioprosthetic valve, a composite valve graft was constructed 
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intraoperatively using either a porcine or pericardial valve and a vascular graft. For patients requiring 
a mechanical valve, a composite valve graft was used. The valve was seated using 2/0 teflon-
pledgeted Ticron sutures in an interrupted mattress fashion. The coronary buttons were re-implanted 
into the graft using a continuous 5/0 Prolene suture (Ethicon). Tissue glue was seldom used and the 
use of Teflon was minimal. In patients undergoing ARR only, it is our routine practice to replace the 
ascending aorta, up to the site of aortic cross clamping.  
Patients requiring AVR and AAR underwent surgery with standard aortic valve prostheses 
and the ascending aorta replaced with an appropriately sized vascular graft, up to the site of aortic 
cross clamping, as in ARR. If the proximal arch is dilated, we perform peripheral cannulation to allow 
clamping of the aorta as distal as possible. 
 
Follow Up 
All patients underwent echocardiography prior to discharge and were followed up at 8 weeks, 6 
months and then annually with echocardiography and CT/ MRI. During follow up, 73% had CT and 
the remainder had MRI. More recently, we have been performing pre operative and follow up MRI to 
assess aortic dimension. All measurements were made by one radiologist and subsequently was 
confirmed by the first author (RB). 
 
Statistical Analysis 
Continuous variables are expressed as mean ± SD and percentage for categorical variables. Median is 
provided for continuous variables not following normal distribution. Student’s t-test was used as 
appropriate to assess the difference between aortic diameter, pre and post operatively, with values of 
p<0.05 considered statistically significant. Analyses were performed using SPSS® (Statistical 
Package for Social Sciences, USA) version 24.  
 
Results 
Between 2005 and 2016, 536 patients underwent ARR or AAR ± concomitant procedures under the 
care of one surgical team. One hundred and sixty eight patients had BAV and satisfied the inclusion 
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criteria. One patient during the study period underwent arch surgery and was excluded from the study.  
Clinical characteristics are shown in Table 1, aortic measurements and BAV fusion pattern in Table 2 
and operative details in Table 3. Isolated ARR or AAR was performed in 127 (75.6%) and 41 (24.4%) 
patients respectively. There were 2 patients (1.2%) who underwent redo surgery.  Five (3%) were 
pregnant at the time of surgery. Homograft ARR was performed in 3 (1.8%) patients with 
endocarditis, one was during pregnancy. Although patients requiring arch or hemiarch replacement 
are not the subject of this study, the median cross clamp, cardiopulmonary bypass and circulatory 
arrest times for arch surgery were 83, 106 and 28 minutes respectively.  
 
Early Mortality and Complications 
Operative mortality and complications are shown in Table 4.  There was one (0.6%) in-hospital death. 
The cause of death in this patient was multi-organ failure. The patient developed acute respiratory 
distress syndrome and renal failure following surgery. Of the 5 patients who were pregnant at the time 
of surgery, there were no maternal deaths, however there was one peri-operative fetal death. One 
patient who had VSRR required coronary artery bypass graft surgery. It was not possible to perform a 
coronary angiogram in her prior to surgery due to access problems and she had a CT angiogram 
instead which showed fairly normal coronary arteries. However, an hour following cessation of 
bypass she developed ECG changes in the lateral leads and bypass grafts were performed.  She did 
well and was discharged 12 days later.  A later angiogram revealed ostial narrowing of the circumflex 
vessel. 
Median intensive care unit (ICU) and hospital stay were 1 and 6 days respectively.  
 
Follow up and Growth of the Aortic Arch 
The median aortic arch dimension measured on CT and / or MRI scan before surgery was 3 cm (range 
2.4-4.1 cm). At a median follow up of 5.9 years (1-139 months), median post operative aortic arch 
dimension was 3 cm (2.4-4.2 cm) . This growth was not significant. 
 
Outcomes Following Hospital Discharge and Later Intervention on the Arch 
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Follow-up was complete in 94% of the patients.  At a median follow up of 5.9 years (1-139 months), 
there was 97% freedom from reoperation and prosthetic valve dysfunction. Five (3%) patients 
underwent redo surgery at a mean interval of 5.3 ± 4.1 years from their first operation.  Two were due 
to bioprosthetic valve failure, one due to homograft failure and two due to endocarditis. None of the 
patients required surgery on the arch or the remaining of their aota. The cause of death, collected from 
family members and medical records, was non cardiac in 7 patients (4.2%).  
 
Comment 
We have shown that over a median follow up of nearly six years, the aortic arch dimensions following 
surgery on proximal aorta in patients with BAV  remained unchanged and that surgery for aortic arch 
dilatation after replacement of the root and ascending aorta is uncommon.  This is consistent with 
recent findings from Iribarne and colleagues [17] who demonstrated a low re-intervention rate in 
patients underoing proximal aortic surgery, with a freedom from reintervention of 92.9% at up to 9 
years. In particular, of the 308 patients with bicuspid aortopathy, only 3 (0.9%) required re-
intervention during follow up, although they have not specified whether this was due to arch 
dilatation. As a result, they have suggested a less aggressive follow up regime in such patients, with 
CT/MRI and transthoracic echocardiogram every 2 years. Park and colleagues [18] reported their 
results of 422 patients with BAV over a 19 year period who underwent aortic root or ascending aortic 
surgery.  Paired echocardiographic measurements of the aortic arch diameter were 3.3 cm 
preoperatively compared to 3.2 cm postoperatively at a median follow-up of 4.2 years.  
The morbidity and mortality related to BAV disease accounts for more than that related to all 
other congenital cardiac diseases combined [19]. BAV aortopathy is multifactorial and is caused by a 
combination of hemodynamic abnormalities and imbalance of matrix metalloproteinases [20]. Using 
MRI and computational fluid dynamics, we have shown that patients with BAV have greater aortic 
flow asymmetry, higher wall shear stress and lower oscillatory shear index in the ascending aorta [8] 
with highest in the greater curvature. This region of the BAV aorta has been associated with medial 
degeneration [21], and extracellular matrix dysregulation and higher elastin degradation [22]. This 
may help explain why some aortas smaller than intervention criteria develop acute aortic dissection. It 
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may also explain why replacement of the aortic valve slows the progression of aortic dilatation [23]. 
However, BAV aortopathy is a heterogeneous condition, and post-AVR aortic dilatation can occur, 
particularly in severe BAV regurgitation [24].  
There was no growth in the aortic arch supporting that high shear stresses are found 
predominantly in the ascending aorta of BAV patients. This may also lend some insights into the 
possible role of proximal aorta hemodynamics in aneurysm formation in patients with connective 
tissue disorders. Indeed, the increased prevalence of aortic complications during pregnancy is likely to 
be related to the increased hemodynamic stresses of a high cardiac output state.  
Cusp fusion pattern has been noted to have an impact on the region of downstream aortic 
dilatation, with the less common pattern of right and non coronary cusp fusion being recognized as 
exterting greater wall shear stress on the aortic arch and as a result dilatation of the aorta [25]. In our 
cohort, only 7.7% had right and non coronary cusp fusion which may reflect the low number of 
patients with dilated aortic arch. The lack of progression in aortic arch diameter again supports our, 
and others’, hypothesis that removal of the bicuspid ‘source’ prevents dilatation of the downstream 
aorta.  
Despite this, some groups have argued for the routine replacement of the aortic arch in 
patients with BAV [26]. Their results of cluster analysis show that dilatation in BAV tends to fall into 
4 clusters: aortic root dilatation only; isolated ascending aorta dilatation; dilatation of the ascending 
aorta and tranverse arch and dilatation of the root, ascending aorta and transverse arch, with the latter 
being the most prevalent. As a result, they have recommended that patients with transverse arch 
dilatation should undergo ARR/AAR and replacement of the transverse arch. Our results do not 
support this view. In our cohort, in which the largest arch diameter was 4.1cm, there was no dilatation 
of the arch at almost 6 years follow up. We would not therefore advocate prophylactic replacement of 
the arch, with its associated risks, in BAV patients, unless they meet criteria for replacement as we 
have already detailed.  
With regard to follow up, we would recommend that imaging and follow up for the valve in 
all patients is required. However,  imaging of the remaining native aorta seems unnecessary. Patients 
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who have cusp fusion pattern of right/non may benefit from follow up due to the predilection of this 
pattern giving rise to arch aneurysms.   
We have been screening patients with aortic aneurysm, BAV and connective tissue disease 
and have been following the recently published ACC/AHA guidelines of operating at 5.0-5.5 cm if 
there is no AV disease and at 4.5cm if there is concomitant AV dysfunction [7]. This decision making 
is partly based on the estimated risk of dissection in patients with BAV to be eight times higher than 
that in the general population [27]. Our series, for elective and urgent cases, is the largest reported in 
the UK to date with favourable results compared to series reporting mortalities of 7-16% and others 
reporting elective and urgent mortality of 3.5-9% [10,28–30]. Stamou and colleagues [31] analyzed 
the STS database and reported that the median number of procedures per year was 2 per center with 
an operative mortality of 4.2%.  However, mortality is lower in centers with high operative volume 
and earlier diagnosis [32,33]. This has recently been reflected in the statement from the American 
College of Cardiology and American Heart Association relating to patients with BAV [7].  
There was only a very small number of BAV patients who presented with normally 
functioning aortic valve who could benefit from VSRR.  This population of patients seems to be 
smaller in the UK compared to the European and US series.  Centres with established experience of 
VSRR technique have reported that only 10% of patients undergoing VSRR have BAV and that the 
majority of these patients undergo either mechanical or biological ARR [33]. In our practice, this may 
reflect late referral by our cardiologists.  During the period of the study we performed 94 VSRR 
where only 3 had BAV.   
Our study is limited by the length of follow up and it may be that at a longer follow up, the 
arch dilates, particularly in the right/non coronary cusp fusion pattern. In addition, the mean age of 
patients was 57. It may be that in younger patients wth longer follow up, some aortas are found to 
dilate.  
In conclusion, our study does not support hemiarch or total arch replacement during ARR or 
AAR in BAV aortopathy and therefore we do not believe that screening the rest of the aorta at mid 
and long term follow-up in these patients is justified.  It also shows that aortic root and ascending 
aortic surgery for aneurysm in BAV patients can be done very safely with low complication rate.   
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Table 1. Baseline clinical characteristics 
 
Demographic 
Total 
(n = 168) 
Age (years) 57 ± 12.8 
Male sex 139 (82.7%) 
Logistic EuroSCORE 5.3 (2-21.3) 
Hypertension 67 (40%) 
Diabetes mellitus 12 (7.1%) 
Coronary artery disease 19 (11.3%) 
Endocarditis 6 (3.6%) 
Pregnancy 5 
Left ventricular function  
Good (EF > 45%)   101 (60.1%) 
Moderate (EF = 30-45%) 47 (28.0%) 
Poor (EF < 30%)  20 (11.9%) 
Aortic valve pathology  
Stenosis 107 (63.7%) 
Regurgitation  58 (34.5%) 
EuroSCORE = European System 
for Cardiac Operative Risk Evaluation; BMI = body mass 
index; EF = ejection fraction. Values presented as mean ± SD 
or median (range) 
 
Table 2. Baseline aortic dimensions 
 
Aortic diameter 
Total 
(n = 168) 
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Table 2. Baseline aortic dimensions 
 
Aortic diameter 
Total 
(n = 168) 
Aortic sinus diameter (cm) 4.3 (3.2-5.5) 
Ascending aorta diameter (cm) 4.9 (3.3-6.5) 
Mid arch diameter (cm)  3 (2.4-4.1) 
BAV cusp fusion pattern  
Left and right  128 (76.2%) 
Right and non coronary 13 (7.7%) 
Left and non coronary 27 (16.1%) 
BAV = bicuspid aortic valve. Values presented median 
(range). *Diameters less than 4.5 cm represent patients who 
have undergone surgery for endocarditis involving the root  
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Table 3. Operative details 
 
Operative detail 
BAV 
(n = 168) 
Procedure type  
Biological ARR 59 (35.1%) 
Mechanical ARR 62 (36.9%) 
VSRR 3 (1.8%) 
Homograft ARR 3 (1.8%) 
AAR ± AVR 41 (24.4%) 
Concomitant Procedures  
CABG 19 (11.3%) 
Mitral valve repair 2 (1.2%) 
Mitral valve replacement 2 (1.2%) 
Redo surgery 2 (1.2%) 
Cross clamp time (mins) 84 (45-153) 
Cardiopulmonary bypass time (mins) 104 (55-203) 
ARR = aortic root replacement; VSRR = valve sparing root 
replacement; AAR = ascending aorta replacement; AVR = 
aortic valve replacement; CABG = coronary artery bypass 
graft surgery. Values presented as median (range). 
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Table 4.  Operative outcomes and complications 
 
Outcome 
Total 
(n = 168) 
In hospital mortality 1 (0.6%) 
TIA/Stroke 1 (0.6%) 
Re-sternotomy for bleeding 1 (0.6%) 
Hemofiltration 3 (1.8%) 
Myocardial infarction 1 
Peripheral vascular injury 0 
Laparotomy/Gastrointestinal complications 0 
Intensive care unit stay (days) 1 (1-17) 
Hospital stay (days) 6 (5-48) 
TIA = transient ischemic attack. Values of hospital and 
intensive care unit stay presented as median (range). 
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Figure Legend 
 
Fig 1. Measurement of mid aortic arch diameter 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
